TL;DR
This study analyzes serological testing patterns for COVID-19 at Michigan Medicine, revealing a significant increase in seropositivity after vaccine rollout. It identifies key demographic and health factors associated with both seeking tests and testing positive, highlighting how these patterns shifted with the introduction of vaccines.
What Problem Does This Paper Address?
The COVID-19 pandemic presented a dual challenge: understanding the prevalence of past infections and assessing the effectiveness of newly developed vaccines. Serological testing is crucial for both, but its patterns and the factors influencing who gets tested and who tests positive can be complex. This paper addresses the need to understand how these patterns evolved, particularly around the critical juncture of vaccine rollout. Specifically, it aims to:
- Describe the overall trends in serological testing.
- Identify characteristics of individuals who sought testing and those who tested positive, both before and after vaccine availability.
- Explore the relationship between diagnostic (RT-PCR) and serological testing.
- Quantify vaccine-induced seropositivity.
Understanding these dynamics is vital for public health strategies, resource allocation, and interpreting population-level immunity.
Methods
The study employed a retrospective, cross-sectional design using electronic health records from Michigan Medicine. Key methods include:
- Data Splitting: The dataset was divided into two periods: pre-vaccine launch (before December 14, 2020) and post-vaccine launch (on or after December 14, 2020).
- Association Analysis: Logistic regression models were used to identify factors associated with:
- Individuals undergoing serologic testing (compared to untested controls).
- Testing positive for SARS-CoV-2 antibodies (compared to negative serology tests or untested controls).
- Stratification: Analyses were stratified by age groups (children, adolescents, adults) and vaccination status.
- Vaccine-Mediated Immunity Assessment: For fully vaccinated individuals, seropositivity rates were calculated at different time points post-vaccination to estimate vaccine effectiveness.
- Sequence Analysis: The temporal relationship between RT-PCR and serological tests was examined.
Datasets
The primary dataset comprised 10,416 individuals who underwent SARS-CoV-2 antibody testing at Michigan Medicine between April 27, 2020, and May 3, 2021. This included 10,932 individual tests. Data were extracted from electronic health records and included demographic information, medical history (pre-existing conditions), smoking status, neighborhood socioeconomic status (SES) indicators, and testing results. Unmatched controls were also used for comparison.
Key Insights and Ideas
- Vaccination as a Turning Point: The introduction of COVID-19 vaccines dramatically shifted seropositivity rates, underscoring the public's interest in assessing immunity.
- Testing Behavior is Not Random: Individuals seeking serological tests were not representative of the general population. Factors like age, smoking, and pre-existing health conditions influenced test-seeking behavior.
- Pre-existing Conditions Matter: Individuals with respiratory, circulatory, and liver diseases were more likely to test positive for past infection, suggesting a potential link between underlying health and susceptibility or detection of prior infection.
- Age and Smoking as Protective Factors: Interestingly, older age and being an ever-smoker were associated with a decreased probability of testing positive for past infection, a finding that warrants further investigation.
- Children and Adolescents Affected by Later Waves: Despite lower eligibility for vaccination, seropositivity increased in younger age groups during the post-vaccine period, indicating community spread continued to impact them.
Key Results
- Seropositivity Surge: Seropositivity in the pre-vaccine period was 9.2%, dramatically increasing to 36.2% in the post-vaccine period (after excluding those tested post-vaccination).
- Vaccine Efficacy: Among fully vaccinated individuals, the seropositivity rate was 85.3%, indicating robust vaccine-mediated immunity.
- Predictors of Testing: Factors like female sex, higher population density, and pre-existing conditions were associated with an increased probability of seeking a serologic test.
- Predictors of Positive Tests (Pre-Vaccine): Age (OR 0.80 per 10 years), ever-smoker status (OR 0.49), respiratory disease (OR 4.38), circulatory disease (OR 2.09), liver disease (OR 2.06), non-Hispanic Black race/ethnicity (OR 2.18), and population density (OR 1.10) were significant predictors.
- Predictors of Positive Tests (Post-Vaccine): Similar factors like age, smoking status, and respiratory, circulatory, and liver diseases remained significant.
- RT-PCR vs. Serology: A significant portion of individuals (14.3%) with a positive diagnostic RT-PCR test subsequently had a positive serologic test, while a smaller group (4.6%) with a negative RT-PCR test later tested positive serologically, potentially indicating asymptomatic infections.
Limitations and Future Work
- Selection Bias: The authors acknowledge that EHR data is inherently biased, as individuals seeking serological tests may not represent the general population. Test-seeking behavior also changed over time, particularly with vaccine availability.
- Unvaccinated Controls: The study relied on unmatched controls, and it was not possible to confirm vaccination status for all individuals, potentially introducing confounding.
- Generalizability: While conducted at a major academic center in a severely affected region, the findings might not be directly generalizable to all populations or regions due to varying testing practices and local epidemic dynamics.
- Future Work: The authors suggest that aggregated data from diverse regional testing centers are needed to validate these findings. Further research is also recommended to understand long-term immunity and the impact of reinfection. They also highlight the need for continued serologic testing to track immunity trends.
Summary updated